<code id='04B426A0EA'></code><style id='04B426A0EA'></style>
      • <acronym id='04B426A0EA'></acronym>
      <center id='04B426A0EA'><center id='04B426A0EA'><tfoot id='04B426A0EA'></tfoot></center><abbr id='04B426A0EA'><dir id='04B426A0EA'><tfoot id='04B426A0EA'></tfoot><noframes id='04B426A0EA'>
      • <optgroup id='04B426A0EA'><strike id='04B426A0EA'><sup id='04B426A0EA'></sup></strike><code id='04B426A0EA'></code></optgroup>
        5. <b id='04B426A0EA'><label id='04B426A0EA'><select id='04B426A0EA'><dt id='04B426A0EA'><span id='04B426A0EA'></span></dt></select></label></b><u id='04B426A0EA'></u>
          <i id='04B426A0EA'><strike id='04B426A0EA'><tt id='04B426A0EA'><pre id='04B426A0EA'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / comprehensive / knowledge      
           
     
           
      
          knowledge 
           
      
           
      
           
       2025-08-12 18:46:19 
   
      
           
      
           
                        
          knowledge  
          
                                   
                 
                                      author：focus   
                                        
                                      
                                      Page View：756
                                  
                                    
          
                                   
          Martin Shkreli Securities Fraud Trial
          Kevin Hagen/Getty Images
          Is this the end of the line for the “pharma bro” with the perpetual smirk?
          Martin Skhreli was found guilty on Friday of three counts of fraud after a five-week trial in federal court in Brooklyn, N.Y. He faces a prison sentence that could stretch years.
          advertisement
          “This was a witch hunt of epic proportions,” Shkreli said outside court after the verdict, the Washington Post reported. “They may have found some broomsticks.”
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          FDA proposes changes to key medical devices approval pathway
                                
                            
          Next article：  
                                      
                                          Duchenne breakthrough therapy leaves behind pioneering families
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles